The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Publication of Suppl.Prospcts and Final Terms

2 Sep 2020 08:26

RNS Number : 7978X
Sampo PLC
02 September 2020
 

Sampo plc

 

2 September 2020

 

Publication of Supplement to Prospectus and Final Terms

 

The following Supplement has been approved by the UK Listing Authority and is available for viewing:

 

 

Supplement dated 25 August 2020 to Prospectus dated 3 April 2020 relating to the EUR 4,500,000,000 (increased from EUR 4,000,000,000) Euro Medium Term Note Programme of Sampo plc.

 

The following Final Terms are available for viewing:

 

 

Final Terms dated 1 September 2020 (the "Final Terms") relating to SAMPO PLC's issue of EUR 1,000,000,000 2.50 per cent. Fixed/Floating Subordinated Rate Dated Notes due 3 September 2052 (the "Notes") under the EUR 4,500,000,000 Euro Medium Term Note Programme of Sampo plc.

 

 

To view the full documents, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/7978X_1-2020-9-2.pdf

 

http://www.rns-pdf.londonstockexchange.com/rns/7978X_2-2020-9-2.pdf

 

 

For further information, please contact

 

Jarmo Salonen

Head of Investor Relations and Group Communications

Tel: +358 10 516 0030

 

Sampo plc

Registered Office

Fabianinkatu 27

FI-00100 Helsinki

Finland

 

 

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPFIFFDAFIFIII

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.